In the current study, we report the up-regulation of HER family receptors and over-expression of several markers involved in RAS/RAF/MAPK and PI3KCA-AKT pathways in HER2-amplified cells compared to parental colon cancer cells. This evidence concerns the gene ERBB2 and colonic neoplasm.